Nicotine blood levels measured after smoking cigarettes designed to release nicotine by heat evaporation (instead of burning)

F. C. Hiller, Keith Melvin Olsen, L. P. Gann, M. L. Erbland

Research output: Contribution to journalArticle

Abstract

Nicotine addiction is a major reason for the resistance of the smoking habit to smoking cessation efforts. Tobacco manufacturers have developed cigarettes with reduced tar and nicotine dose to reduce the toxicity of cigarettes. The Premier® cigarette is one extreme example of such an effort. This product almost totally eliminates toxic constituents, with the exception of nicotine. The authors studied the effectiveness of this product for nicotine delivery by measuring plasma nicotine levels in smokers who were novices to the Premier® product and compared the results with the nicotine levels each smoker attained after use of his/her usual cigarette. Smokers attained a nicotine level of 19.3 ± 8.5 ng/ml by smoking their own cigarettes compared to a level of 9.6 ± 6.0 ng/ml (p < 0.01) with the Premier® product. A subjective survey of study subjects indicated that satiation with the new product was less than with the subjects usual cigarettes.

Original languageEnglish (US)
Pages (from-to)77-81
Number of pages5
JournalS.T.P. Pharma Sciences
Volume4
Issue number1
StatePublished - Jan 1 1994

Fingerprint

Nicotine
Tobacco Products
Hot Temperature
Smoking
Satiation
Tars
Poisons
Smoking Cessation
Habits
Tobacco

Keywords

  • cigarette smoking
  • nicotine
  • nicotine addiction
  • nicotine blood levels

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Nicotine blood levels measured after smoking cigarettes designed to release nicotine by heat evaporation (instead of burning). / Hiller, F. C.; Olsen, Keith Melvin; Gann, L. P.; Erbland, M. L.

In: S.T.P. Pharma Sciences, Vol. 4, No. 1, 01.01.1994, p. 77-81.

Research output: Contribution to journalArticle

Hiller, F. C. ; Olsen, Keith Melvin ; Gann, L. P. ; Erbland, M. L. / Nicotine blood levels measured after smoking cigarettes designed to release nicotine by heat evaporation (instead of burning). In: S.T.P. Pharma Sciences. 1994 ; Vol. 4, No. 1. pp. 77-81.
@article{6872e3b77b4b45579d5f3d37491a9b17,
title = "Nicotine blood levels measured after smoking cigarettes designed to release nicotine by heat evaporation (instead of burning)",
abstract = "Nicotine addiction is a major reason for the resistance of the smoking habit to smoking cessation efforts. Tobacco manufacturers have developed cigarettes with reduced tar and nicotine dose to reduce the toxicity of cigarettes. The Premier{\circledR} cigarette is one extreme example of such an effort. This product almost totally eliminates toxic constituents, with the exception of nicotine. The authors studied the effectiveness of this product for nicotine delivery by measuring plasma nicotine levels in smokers who were novices to the Premier{\circledR} product and compared the results with the nicotine levels each smoker attained after use of his/her usual cigarette. Smokers attained a nicotine level of 19.3 ± 8.5 ng/ml by smoking their own cigarettes compared to a level of 9.6 ± 6.0 ng/ml (p < 0.01) with the Premier{\circledR} product. A subjective survey of study subjects indicated that satiation with the new product was less than with the subjects usual cigarettes.",
keywords = "cigarette smoking, nicotine, nicotine addiction, nicotine blood levels",
author = "Hiller, {F. C.} and Olsen, {Keith Melvin} and Gann, {L. P.} and Erbland, {M. L.}",
year = "1994",
month = "1",
day = "1",
language = "English (US)",
volume = "4",
pages = "77--81",
journal = "S.T.P. Pharma Sciences",
issn = "1157-1489",
publisher = "Editions de Sante",
number = "1",

}

TY - JOUR

T1 - Nicotine blood levels measured after smoking cigarettes designed to release nicotine by heat evaporation (instead of burning)

AU - Hiller, F. C.

AU - Olsen, Keith Melvin

AU - Gann, L. P.

AU - Erbland, M. L.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Nicotine addiction is a major reason for the resistance of the smoking habit to smoking cessation efforts. Tobacco manufacturers have developed cigarettes with reduced tar and nicotine dose to reduce the toxicity of cigarettes. The Premier® cigarette is one extreme example of such an effort. This product almost totally eliminates toxic constituents, with the exception of nicotine. The authors studied the effectiveness of this product for nicotine delivery by measuring plasma nicotine levels in smokers who were novices to the Premier® product and compared the results with the nicotine levels each smoker attained after use of his/her usual cigarette. Smokers attained a nicotine level of 19.3 ± 8.5 ng/ml by smoking their own cigarettes compared to a level of 9.6 ± 6.0 ng/ml (p < 0.01) with the Premier® product. A subjective survey of study subjects indicated that satiation with the new product was less than with the subjects usual cigarettes.

AB - Nicotine addiction is a major reason for the resistance of the smoking habit to smoking cessation efforts. Tobacco manufacturers have developed cigarettes with reduced tar and nicotine dose to reduce the toxicity of cigarettes. The Premier® cigarette is one extreme example of such an effort. This product almost totally eliminates toxic constituents, with the exception of nicotine. The authors studied the effectiveness of this product for nicotine delivery by measuring plasma nicotine levels in smokers who were novices to the Premier® product and compared the results with the nicotine levels each smoker attained after use of his/her usual cigarette. Smokers attained a nicotine level of 19.3 ± 8.5 ng/ml by smoking their own cigarettes compared to a level of 9.6 ± 6.0 ng/ml (p < 0.01) with the Premier® product. A subjective survey of study subjects indicated that satiation with the new product was less than with the subjects usual cigarettes.

KW - cigarette smoking

KW - nicotine

KW - nicotine addiction

KW - nicotine blood levels

UR - http://www.scopus.com/inward/record.url?scp=0028053063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028053063&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 77

EP - 81

JO - S.T.P. Pharma Sciences

JF - S.T.P. Pharma Sciences

SN - 1157-1489

IS - 1

ER -